Roche Touts Safety Profile For NMOSD Drug Satralizumab

Approvals Sought For Rare Disorder

 
• By Kevin Grogan
  
Blue man
Rare: NMOSD affects 10,000 people in Europe, • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Neurological

More from Therapeutic Category